GSK plc (GSK.L) Deep Dive Video

Name: GSK plc (GSK.L) Deep Dive Video | Flash
Uploaded: 2026-02-04T18:43:22.788Z
Description: GSK’s specialty-and-vaccine transformation, pipeline expansion, and 11.6% base-case annualized return outweigh the 2028–2030 HIV patent-cliff risk.

Summary

GSK’s specialty-and-vaccine transformation, pipeline expansion, and 11.6% base-case annualized return outweigh the 2028–2030 HIV patent-cliff risk.

View GSK.L stock page · Read the GSK.L research report

Loading the video player…

Loading Flash…